Life sciences stocks fall on NIH funding concerns
Source: SeekingAlpha
2025-01-23 12:55:36 ET
More on Illumina, Pacific Biosciences of California, etc.
- Illumina, Inc. (ILMN) 43rd Annual JPMorgan Healthcare Conference - (Transcript)
- 10x Genomics: Struggling Amid Operational Challenges
- Illumina And Grail In 2025? Grounds For Optimism, If Mistakes Aren't Repeated
- Illumina reports preliminary Q4 results, provides 2025 expectations
- PacBio announces preliminary Q4 revenue of $39.2M
Read the full article on Seeking Alpha
For further details see:
Life sciences stocks fall on NIH funding concerns
Bio-Rad Laboratories Inc. Class A
NASDAQ: BIO
BIO Trading
1.56% G/L:
$281.74 Last:
236,389 Volume:
$281.82 Open:
BIO Latest News
BIO Stock Data
$8,088,674,023
21,121,296
0.01%
179
N/A
Biotechnology & Life Sciences
Healthcare
US
Hercules
